HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Lipid disorders in non-insulin dependent diabetes--principles of treatment].

Abstract
Hyperlipoproteinemia is one of the main coronary risk factors. Lipid metabolism disorders occur in about 40-60% of patients with NIDDM. Hyperlipidemia in diabetics is related to diabetes control, presence of diabetic nephropathy, diet, some drugs and genetic factors. Lipid metabolism disorders in NIDDM comprise qualitative changes--usually increase of serum triglyceride concentration and decrease of HDL--cholesterol, and qualitative changes of lipoprotein composition, glycation and oxidation. The first steps of hypolipemic therapy are good control of diabetes, reduction of overweight, hypolipidemic diet, and if a goal level is not achieved--farmacotherapy. Hypolipidemic treatment should be relevant in reduction of cardiovascular diseases in diabetic patients.
AuthorsB Idzior-Waluś
JournalPrzegla̧d lekarski (Przegl Lek) Vol. 53 Issue 9 Pg. 653-9 ( 1996) ISSN: 0033-2240 [Print] POLAND
Vernacular TitleZaburzenia lipidowe w cukrzycy nieinsulinozaleznej--zasady leczenia.
PMID8992531 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Cholesterol, HDL
  • Triglycerides
Topics
  • Cholesterol, HDL (blood)
  • Coronary Disease (etiology, prevention & control)
  • Diabetes Mellitus, Type 2 (complications, metabolism, therapy)
  • Humans
  • Hyperlipidemias (complications, metabolism, therapy)
  • Hyperlipoproteinemias (complications)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: